Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Recombinant Protein Expression System Reduces Production Costs and Speeds Time to Market

By LabMedica International staff writers
Posted on 06 Oct 2009
An innovative recombinant protein system overcomes conventional microbial expression difficulties by secreting correctly folded, active proteins directly into the growth media. More...
Breakthrough expression system reduces production costs and speeds time to market.

Ajinomoto AminoScience, LLC (Raleigh, NC,USA) announced the launch of Corynex recombinant protein expression system streamlined , more efficient process to express proteins. "Ajinomoto's innovative Corynex recombinant protein expression system reinforces 50 years of leadership within the fermentation and expression fields,” commented Jack Heaton, president of Ajinomoto AminoScience. "With the debut of our new system, we demonstrate that Ajinomoto is an unrivaled industry leader.”

This advanced technology is Ajinomoto's answer to a recent analysis of biotechnology manufacturing by BioPlan Associates, a biotechnology marketing research firm (Rockville, MD, USA). In the January 2009, the firm released a study that outlines the need for advances in manufacturing. The study describes a "reluctance” by companies to modernize with new technology and methodologies so products can be made "more efficiently and to higher clinical standards.”

"This new process shows Ajinomoto's willingness to invest in scientific efforts to improve expression systems,” said Mr. Heaton. "We have answered the industry's call to develop better technology to meet our customers' needs.”

Ajinomoto, one of the worlds' largest manufacturers of amino acids, was the first company in the world to identify, customize, and market amino acids. The company is the only U.S. manufacturer of cGMP pharmaceutical grade amino acids. Key applications include use in therapeutic pharmaceutical development, cell culture media, parenteral and clinical nutrition, health foods, and food applications.

Ajinomoto AminoScience is a supplier of pharmaceutical grade amino acids. Ajinomoto created the standards that have become the accepted benchmark for the amino acid industry. Since its development, the company has provided a steady supply of high quality amino acids while vigorously pursuing research programs and improving manufacturing processes.

Related Links:

Ajinomoto Amino Science



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.